Product Information

SEVELAMER HCL 800 MG TABLET is a generic product labeled by Aurobindo Pharma Limited, priced at $0.6842 per EA under NDC 59651008818. Its NADAC has been published 158 times since Nov 8, 2023.

FDA first approved this application on Jul 11, 2023. Its Orange Book therapeutic-equivalence code is BX.

SEVELAMER HCL 800 MG TABLET

SEVELAMER HYDROCHLORIDE
$0.6842per EA

Strength

800 mg/1

NDC

59651008818

Classification

Generic

Dosage Form

TABLET, FILM COATED

Route

ORAL

Effective Date

10/21/2026

Active Ingredients

SEVELAMER HYDROCHLORIDE

Approval Type

Generic (ANDA)

FDA Application

ANDA212599

FDA Approved

7/11/2023

TE Code

BX

On Market Since

7/11/2023

Pharmacological Classes

Phosphate Binder
Phosphate Chelating Activity

Price Statistics

The NADAC for SEVELAMER HCL 800 MG TABLET has been published 158 times since Nov 8, 2023, and over the history we have for it it has declined 70.7%. The table below summarizes its recorded NADAC range and movement.

Current price$0.6842 per EA
All-time high$2.3333 (Nov 15, 2023)
All-time low$0.6842 (Oct 21, 2026)
52-week high$1.1940
52-week low$0.6842
Median price$1.2863
Average price$1.2936
Largest weekly change-37.7% (May 22, 2024)
Weeks tracked158
Tracking sinceNov 8, 2023

Price History

1W

0.0%

1M

-1.6%

3M

-2.6%

6M

-11.5%

1Y

-49.2%

3Y

-70.7%

5Y

N/A

All

-70.7%

Generic Alternatives

No other NADAC-published product shares this drug's active ingredient and strength in a comparable dosage form. Compare the broader picture on the SEVELAMER HYDROCHLORIDE market page.

Lowest-Cost Alternatives

No alternatives available

No alternatives found with the same active ingredient and strength in a comparable dosage form.

Continue researching this drug

Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.

Frequently asked questions

What is the NADAC price of SEVELAMER HCL 800 MG TABLET?

The current National Average Drug Acquisition Cost (NADAC) for SEVELAMER HCL 800 MG TABLET, manufactured by Aurobindo Pharma Limited, is $0.6842 per EA (NDC 59651008818), effective Nov 11, 2026.

How has the price of SEVELAMER HCL 800 MG TABLET changed over time?

Over the history we have for it, the NADAC for SEVELAMER HCL 800 MG TABLET has declined 70.7%. It has been tracked across 158 weekly CMS publications since Nov 8, 2023.

What are the highest and lowest recorded NADAC prices for SEVELAMER HCL 800 MG TABLET?

Since Nov 8, 2023, the NADAC for SEVELAMER HCL 800 MG TABLET has ranged from a low of $0.6842 (Oct 21, 2026) to a high of $2.3333 (Nov 15, 2023), with a median of $1.2863 per EA.

Are there cheaper alternatives to SEVELAMER HCL 800 MG TABLET?

No other NADAC-published product currently shares the active ingredient and strength of SEVELAMER HCL 800 MG TABLET in a comparable dosage form, so no direct lower-cost alternative is listed.

Who manufactures SEVELAMER HCL 800 MG TABLET?

SEVELAMER HCL 800 MG TABLET (NDC 59651008818) is labeled by Aurobindo Pharma Limited, and CMS classifies it as a generic product.